Jump to content
TedderVision

Doomhammer

CH Democrats
  • Content count

    668
  • Joined

  • Last visited

  • Days Won

    6

Doomhammer last won the day on July 11

Doomhammer had the most liked content!

Community Reputation

55 Excellent

2 Followers

About Doomhammer

  • Rank
    Advanced Member

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Doomhammer

    Rural Hospital Access Act

    Mr. Speaker, There is relevance. The bill's purpose is to, " To amend title XVIII of the Social Security Act to make permanent the extension of the Medicare-dependent hospital (MDH) program and the increased payments under the Medicare low-volume hospital program." Essentially, the bill is to improve hospitals, medicare, and lightly address health care. In order to assist in the health of American citizens who might qualify for medicare or who have health care needs as well as the hospitals ability to offer pain relief to their clients, legalizing marijuana will offer an alternative to some of the current medical practices offered by hospitals and medical institutions. 92% of patients who have used medical marijuana in states where it is legal have claimed it worked.* This bill is lightly addressing our health care system and by legalizing marijuana, our nation will take a much greater step in providing assistance and freedom to the American people. Instead of making the language of the bill only for medical marijuana, it is more convenient to legalize it in general so that there are fewer regulations on cannibus uses. In addition, this amendment would help boost our economy. This boost will lead to more business owners, more jobs, and more income taxes from marijuana which can then be used to help fund medicare. This amendment is relevant. What would be germane would be military spending in an infrastructure bill. I yield. OOC: *https://www.washingtonpost.com/news/wonk/wp/2014/10/01/92-of-patients-say-medical-marijuana-works/?utm_term=.5e602e7b3410
  2. Doomhammer

    Infrastructure, Jobs, and National Security Act

    Mr. Speaker, I object. In addition, I have an amendment proposal to strike Section 5 completely in order to save the tax-payer's money and avoid unnecessary spending. This is not the 1910s. We do not need more ships at this time. Perhaps a compromise of fewer ships, but $300,000,000,000 is unnecessary especially when our house just voted to give corporations egregious tax cuts. For national security and military purposes, we should be investing in drones and the airforce as this is the 21st century. President Theodore Roosevelt's belief that a nation must control the oceans was before we developed aircraft, drones, and the technology we have today. In addition, I believe this is an infrastructure bill that should focus on infrastructure not additional military spending. A BILL To rebuild America's infrastructure, provide America's military with next generation equipment, and create millions of jobs. SECTION 1. SHORT TITLE. (a) This act shall be cited as the Infrastructure, Jobs, and National Security Act (IJNSA). SEC. 2. REBUILD AMERICA FUND. (a) $100,000,000,000 will be appropriated annually from Fiscal Year 2019 through Fiscal Year 2028 for the construction of infrastructure projects, to be directed to each State government in the form of a block grant, with the total appropriation being divided on a per capita basis according to the total population of each State. (b) "Infrastructure" shall be defined as the basic physical and organizational structures and facilities, including but not limited to buildings, roads, bridges, utilities, and power supplies needed for the operation of a society or enterprise. SEC. 3. ENDING TAX HAVEN ABUSE. (a) The Department of the Treasury shall be authorized to impose restrictions on foreign jurisdictions or financial institutions operating in the United States that are of primary money laundering concern or that significantly impede U.S. tax enforcement. (b) Title 26 of the United States Code (the Internal Revenue Code) shall be amended to: (1) Authorize the Department of the Treasury to expand reporting requirements for U.S. persons who hold an interest in a passive foreign investment company; (2) establish a rebuttable presumption against the validity of transactions by institutions that do not comply with reporting requirements under the Foreign Account Tax Compliance Act; (3) treat foreign corporations managed and controlled primarily in the United States as domestic corporations for tax purposes; (4) require tax withholding agents and financial institutions to report certain information about beneficial owners of foreign-owned financial accounts; (5) treat swap payments sent offshore as taxable U.S. source income; and (6) Authorize the Department of the Treasury to impose additional requirements for third party summonses used to obtain information in tax investigations that do not identify the person with respect to whose liability the summons is issued (i.e., John Doe summons). (c) The Securities Exchange Act of 1934 shall be amended to: (1) require corporations registered with the Securities and Exchange Commission to report annually, on a country-by country basis, on employees, gross revenues, payments made to governments, and other financial information; and (2) impose a fine for failure to disclose any holdings or transactions involving equity or debt instruments known to involve a foreign entity that would otherwise be subject to disclosure requirements. (d) Investment advisers and persons engaged in forming new business entities shall hereby subject to all current anti-money laundering requirements and laws. (e) The Department of the Treasury shall be authorized to impose new restrictions on U.S. corporations and other entities with foreign income with respect to: (1) tax deductions allocable to deferred foreign income, (2) the recalculation of foreign income taxes, (3) intangible property transferred overseas, (4) tax evasion activities by U.S. corporations reincorporating in a foreign country, and (5) the interest expense tax deduction of certain subsidiaries of foreign corporations with excess domestic indebtedness in order to prevent such deductions from being considered to drastically reduce tax income owed to the United States. (f) The rules on taxation of inverted entities (i.e., U.S. corporations that acquire foreign companies to reincorporate in a foreign jurisdiction with income tax rates lower than the United States) shall be amended to provide that a foreign corporation that acquires the properties of a U.S. corporation or partnership after the date of passage of this Act shall be treated as an inverted corporation and thus subject to U.S. taxation if, after such acquisition: (1) it holds more than 50% of the stock of the new entity (expanded affiliated group), or (2) the management or control of the new entity occurs primarily within the United States and the new entity has significant domestic business activities. SEC. 4. ESTABLISHMENT OF CIVILIAN CONSERVATION CORPS. (a) This bill authorizes the President to establish a Civilian Conservation Corps to employ U.S. citizens ages 18-35 in the construction, maintenance, and carrying on of works of a public nature, including but not limited to the forestation of U.S. and state lands, prevention of forest fires, floods, and soil erosion, and construction and repair of National Park System paths and trails. (b) The President may extend corps activities to state- and private-owned lands to prevent and control forest fires and floods and attacks of forest tree pests and diseases. (c) The President is authorized to provide housing and transportation for corps employees. (d) There are authorized to be appropriated to the President $20,000,000,000 annually from Fiscal Year 2019 through Fiscal Year 2028 to establish and operate a Civilian Conservation Corps under this Act. (e) Beginning in the year following the enactment of this act, carried interest shall be taxed according to existing laws pertaining to income taxation. SEC. 5. MILITARY REARMAMENT FUND. (a) $300,000,000,000 will be appropriated to the Department of Defense for the following purposes: (1) The renewal and development of the Future Combat System (FCS) including but not limited to the development and production of replacements for the M-1 Abrams tank, the M-2 Bradley IFV, and the M-109A6 Paladin SP artillery system (2) The production of 10 Virginia Class Submarines. (3) The production of 10 Zumwalt Class Destroyers. (4) The production of 10 National Security Cutters. (5) The production of 100 B-21 Raiders. (6) The research, development, and production of a replacement of the M-4 Carbine. (7) Any other purpose the Secretary of Defense authorizes. (b) The money appropriated in this section will remain available until it is spent entirely. (c) All equipment procured by the Department of Defense must be manufactured entirely in the United States when available, including all components and materials of said equipment. SEC. 6. AIR TRAVEL MODERNIZATION. (a) The American Air Navigation Services Corporation is hereby established as a federally chartered, not-for-profit, user-fee funded corporation under the continued oversight of the Federal Aviation Administration and the Department of Transportation. (b) The Department of Transportation (DOT) shall transfer to the corporation: (1) within one year of the date of enactment of this act Federal Aviation Administration (FAA) employees, property, and facilities; and (2) within one year of the date of enactment of this act, operational control of FAA air traffic services. (c) DOT shall establish a Safety Oversight and Certification Advisory Committee. (d) The FAA shall establish: (1) the FAA Task Force on Flight Standards Reform, and (2) a Regulatory Consistency Communications Board. (e) The FAA shall establish a safety workforce training strategy. (f) DOT shall take appropriate actions to promote U.S. aerospace standards, products, and services abroad. (g) DOT shall modify FAA's final rule published August 19, 1994, relating to flight duty limitations and rest requirements to ensure that: (1) a flight attendant scheduled for a duty period of 14 hours or less is given a scheduled rest period of at least 10 consecutive hours, and (2) the rest period is not reduced under any circumstances. (h) DOT shall develop a comprehensive plan to accelerate the integration of civil unmanned aircraft systems (drones) into the national airspace system. (i) The FAA shall initiate a review of its strategic aviation cybersecurity plan. (j) DOT shall establish a remote air traffic control tower pilot program for rural or small communities. SEC. 7. ENACTMENT. (a) Unless otherwise stated, this act shall take effect immediately.
  3. Doomhammer

    Rural Hospital Access Act

    Mr. Speaker, I object to UC as I have an additional amendment to propose. SEC. 4. Application of the Controlled Substances Act to marijuana. (a) In general.—Part A of the Controlled Substances Act (21 U.S.C. 801 et seq.) is amended by adding at the end the following: “SEC. 103. Application of this Act to marijuana. “(a) Prohibition on certain shipping or transportation.—This Act shall not apply to marijuana, except that it shall be unlawful only to ship or transport, in any manner or by any means whatsoever, marijuana, from one State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, into any other State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, or from any foreign country into any State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, when such marijuana is intended, by any person interested therein, to be received, possessed, sold, or in any manner used, either in the original package or otherwise, in violation of any law of such State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof. “(b) Penalty.—Whoever knowingly violates subsection (a) shall be fined under title 18, United States Code, imprisoned not more than 1 year, or both.”. (b) Table of contents.—The table of contents for the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91–513; 84 Stat. 1236) is amended by striking the item relating to section 103 and inserting the following: “Sec. 103. Application of this Act to marijuana.”. SEC. 5. Deregulation of marijuana. (a) Removed from schedule of controlled substances.—Subsection (c) of Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended— (1) by striking “marijuana”; and (2) by striking “tetrahydrocannabinols”. (b) Removal of prohibition on import and export.—Section 1010(b) of the Controlled Substances Import and Export Act (21 U.S.C. 960) is amended— (1) in paragraph (1)— (A) in subparagraph (F), by inserting “or” after the semicolon; (B) by striking subparagraph (G); and (C) by redesignating subparagraph (H) as subparagraph (G); (2) in paragraph (2)— (A) in subparagraph (F), by inserting “or” after the semicolon; (B) by striking subparagraph (G); and (C) by redesignating subparagraph (H) as subparagraph (G); (3) in paragraph (3), by striking “paragraphs (1), (2), and (4)” and inserting “paragraphs (1) and (2)”; (4) by striking paragraph (4); and (5) by redesignating paragraphs (5), (6), and (7) as paragraphs (4), (5), and (6), respectively. SEC. 4. Conforming amendments to Controlled Substances Act. The Controlled Substances Act (21 U.S.C. 801 et seq.) is amended— (1) in section 102(44) (21 U.S.C. 802(44)), by striking “marijuana,”; (2) in section 401(b) (21 U.S.C. 841(b))— (A) in paragraph (1)— (i) in subparagraph (A)— (I) in clause (vi), by inserting “or” after the semicolon; (II) by striking (vii); and (III) by redesignating clause (viii) as clause (vii); (ii) in subparagraph (B)— (I) by striking clause (vii); and (II) by redesignating clause (viii) as clause (vii); (iii) in subparagraph (C), by striking “subparagraphs (A), (B), and (D)” and inserting “subparagraphs (A) and (B)”; (iv) by striking subparagraph (D); (v) by redesignating subparagraph (E) as subparagraph (D); and (vi) in subparagraph (D)(i), as redesignated, by striking “subparagraphs (C) and (D)” and inserting “subparagraph (C)”; (B) by striking paragraph (4); and (C) by redesignating paragraphs (5), (6), and (7) as paragraphs (4), (5), and (6), respectively; (3) in section 402(c)(2)(B) (21 U.S.C. 842(c)(2)(B)), by striking “, marijuana,”; (4) in section 403(d)(1) (21 U.S.C. 843(d)(1)), by striking “, marijuana,”; (5) in section 418(a) (21 U.S.C. 859(a)), by striking the last sentence; (6) in section 419(a) (21 U.S.C. 860(a)), by striking the last sentence; (7) in section 422(d) (21 U.S.C. 863(d))— (A) in the matter preceding paragraph (1), by striking “marijuana,”; and (B) in paragraph (5), by striking “, such as a marijuana cigarette,”; and (8) in section 516(d) (21 U.S.C. 886(d)), by striking “section 401(b)(6)” each place the term appears and inserting “section 401(b)(5)”.
  4. Doomhammer

    Allow States and Victims to Fight Online Sex Trafficking Act

    OOC: The emoticon is supposed to be Sec. 8 ) . The 8 and the ) together makes the emoticon.
  5. Doomhammer

    Allow States and Victims to Fight Online Sex Trafficking Act

    Mr. Speaker, I object to UC due to an amendment to strengthen the bill. We can do everything in this bill and do much more. I would like to propose the following amended section 7 with a title change due to the content being added: SECTION 1. SHORT TITLE. This Act may be cited as the “Allow States and Victims to Fight Online Sex Trafficking Act”. SECTION 1. SHORT TITLE. This Act may be cited as the “Collaborative Effort Against Human Trafficking Act”. SEC. 7. HUMAN TRAFFICKING PREVENTION COORDINATOR. Sub-Section 1 The Secretary of Transportation shall designate an official within the Department of Transportation who shall— (1) coordinate human trafficking prevention efforts across modal administrations in the Department of Transportation and with other departments and agencies of the Federal Government; and (2) in coordinating such efforts, take into account the unique challenges of combating human trafficking within different transportation modes. Sub-Section 2. EXPANSION OF OUTREACH AND EDUCATION PROGRAM. Section 31110(c)(1) of title 49, United States Code, is amended by adding at the end the following: ‘‘The program authorized under this subsection may support, in addition to funds otherwise available for such purposes, the recognition, prevention, and reporting of human trafficking, while deferring to existing resources, as practicable.’’. Sub-Section 3. EXPANSION OF COMMERCIAL DRIVER’S LICENSE FINANCIAL ASSISTANCE PROGRAM. Section 31313(a)(3) of title 49, United States Code, is amended— (1) in subparagraph (D), by striking ‘‘or’’ at the end; (2) by redesignating subparagraph (E) as subparagraph (F); and (3) by inserting after subparagraph (D) the following: ‘‘(E) support, in addition to funds otherwise available for such purposes, the recognition, prevention, and reporting of human trafficking; or’’. S. 1536—2 Sub-Section 4. ESTABLISHMENT OF THE DEPARTMENT OF TRANSPORTATION ADVISORY COMMITTEE ON HUMAN TRAFFICKING. (a) ESTABLISHMENT.—The Secretary shall establish an advisory committee on human trafficking. (b) MEMBERSHIP.— (1) COMPOSITION.—The Committee shall be composed of not more than 15 external stakeholder members whose diverse experience and background enable them to provide balanced points of view with regard to carrying out the duties of the Committee. (2) SELECTION.—The Secretary shall appoint the external stakeholder members to the Committee, including representatives from— (A) trafficking advocacy organizations; (B) law enforcement; and (C) trucking, bus, rail, aviation, maritime, and port sectors, including industry and labor. (3) PERIODS OF APPOINTMENT.—Members shall be appointed for the life of the Committee. (4) VACANCIES.—A vacancy in the Committee shall be filled in the manner in which the original appointment was made and shall not affect the powers or duties of the Committee. (5) COMPENSATION.—Committee members shall serve with-out compensation. (c) AUTHORITY.—Not later than 9 months after the date of enactment of this Act, the Secretary shall establish and appoint all members of the Committee. (d) DUTIES.— (1) RECOMMENDATIONS FOR THE DEPARTMENT OF TRANSPORTATION .—Not later than 18 months after the date of enactment of this Act, the Committee shall make recommendations to the Secretary on actions the Department can take to help combat human trafficking, including the development and implementation of— (A) successful strategies for identifying and reporting instances of human trafficking; and (B) recommendations for administrative or legislative changes necessary to use programs, properties, or other resources owned, operated, or funded by the Department to combat human trafficking. (2) BEST PRACTICES AND RECOMMENDATIONS.— (A) IN GENERAL.—The Committee shall develop recommended best practices for States and State and local transportation stakeholders to follow in combating human trafficking. (B) DEVELOPMENT—The best practices shall be based on multidisciplinary research and promising, evidence-based models and programs. (C) CONTENT.—The best practices shall be user-friendly, incorporate the most up-to-date technology, and include the following: (i) Sample training materials. (ii) Strategies to identify victims. (iii) Sample protocols and recommendations, Including— (I) strategies to collect, document, and share data across systems and agencies; S. 1536—3 (II) strategies to help agencies better understand the types of trafficking involved, the scope of the problem, and the degree of victim interaction with multiple systems; and (III) strategies to identify effective pathways for State agencies to utilize their position in educating critical stakeholder groups and assisting victims. (D) INFORMING STATES OF BEST PRACTICES.—The Secretary shall ensure that State Governors and State departments of transportation are notified of the best practices and recommendations. (e) REPORTS.—Not later than 2 years after the date of enactment of this Act, the Secretary shall— (1) submit a report on the actions of the Committee described in subsection (d) to— (A) the Committee on Commerce, Science, and Transportation of the Senate; and (B) the Committee on Transportation and Infrastructure of the House of Representatives; and (2) make the report under paragraph (1) publicly available both physically and online. (f) DEFINITIONS.—In this section: (1) COMMITTEE.—The term ‘‘Committee’’ means the Department of Transportation Advisory Committee on Human Trafficking established under subsection (a). (2) HUMAN TRAFFICKING.—The term ‘‘human trafficking’’ means an act or practice described in paragraph (9) or paragraph (10) of section 103 of the Trafficking Victims Protection Act of 2000 (22 U.S.C. 7102). (3) SECRETARY.—The term ‘‘Secretary’’ means the Secretary of Transportation. (Sec. 7) This section states that this bill does not limit federal or state civil actions or criminal prosecutions that are not preempted by section 230 of the Communications Act of 1934. (Sec. 😎 This section states that this bill does not limit federal or state civil actions or criminal prosecutions that are not preempted by section 230 of the Communications Act of 1934.
  6. Doomhammer

    Caroline Anne Jones (Republican)

    Welcome!
  7. Doomhammer

    Michael K. Murphy (Republican)

    Welcome!
  8. Doomhammer

    Carmen Cardenas (Republican)

    Welcome!
  9. Doomhammer

    American National Security Act

    Mr. Speaker, I just want to share the irony that Republicans have boasted about their past election win and have told Democrats to "deal with" the results of this past election. We have been told to not oppose the President or the Republicans because "the people chose them" as they say. Now the tables have turned. The house, who represents Americans all across the country, has voted on the people's behalf to remove the border wall from what was a comprehensive and collaborative effort from both sides. I wish they would take their own advice and simply "deal with it." They lost the vote because the wall is an expensive and ineffective solution to their problem. This bill with another wall proposal is a wasted docket slot. Something much better could have been in its place. What about an education bill, Mr. Speaker? How about a bill that protects the environment as opposed to one that exploits it? An energy bill, a student loan bill, a small business aid bill, or anything of actual value to the American people. We shouldn't waste docket time on an obsolete concept or bill. I yield, Mr. Speaker.
  10. Doomhammer

    American National Security Act

    I Second.
  11. Doomhammer

    Rural Broadband Access Act

    IN THE HOUSE OF THE UNITED STATES ----------------------------------------------- Ms. Vanderfleet (For herself and Mr. Ward @Jsawrie ), submits… A BILL… To authorize the Secretary of Agriculture to establish a program of awarding grants to service providers to expand broadband access in rural areas. Be it enacted by the United States Senate, and House of Representatives assembled, that. Section 1. Short Title This legislation may be cited as the ‘Rural Broadband Access Act” Section 2. Amendments to the Rural Electrification Act of 1936 The Rural Electrification Act of 1936 is amended -- in subsection (a) by striking ‘loans and loan guarantees’ and inserting ‘loans, loan guarantees, and grants’ in subsection © - in paragraph (1) by inserting ‘, and may make grants’ after ‘loans’ in paragraph (2) by inserting ‘, and in making grants,’ before ‘under paragraph (1); in subsection (d) by adding at the end of the following; ‘(8) ADDITIONAL PROCESS- The Secretary shall establish a process under which an incumbent service provider which, as of the date of the publication notice under paragraph (5) with respect to the application submitted by the provider, is providing broadband service to a remote rural area, may (but shall not be required to) submit to the Secretary, not less than 15 and not more than 30 days after that date, information regarding the broadband services that the provider offers in the proposed service territory, so that the Secretary may assess the application. in subsection (e) by adding at the end of the following: ‘(3) REQUIREMENT - In considering the technology needs of customers in a proposed service territory, the Secretary shall take into consideration the upgrade, or replacement cost of the construction or acquisition of facilities and equipment in the territory’ ; by redesignating subsections (k) and (l) as subsections (l) and (m), respectively, and inserting after subsection (j) the following: ‘(k) Matching Grants - ‘(1) IN GENERAL - The Secretary may make a grant to an entity for a project with respect to which a loan, or a loan guarantee is made under this section. ‘(2) AMOUNT - ‘(A) IN GENERAL - The amount of the grant shall not exceed 20% of the cost of the project. ‘(B) MATCH REQUIREMENT - The Secretary may not make a grant to an entity for a project unless the entity has made a binding commitment to the Secretary that the entity will provide for the project, from non-Federal sources, an amount equal to the amount of the grant.’; in subjection (l) (as so redesignated) - by striking paragraph (1) and inserting the following: ‘(1) LIMITATION ON AUTHORIZATIONS OF APPROPRIATIONS - There is authorized to be appropriated to the Secretary to carry out this section such sums may be necessary for each of fiscal years 2019 through 2024, to remain available until expended. Of the sums made available to carry out this section for a fiscal year - ‘(A) 70% shall be made available for the cost of loans, and loan guarantees under this section; and ‘(B) 30% shall be made available for grants, under this section.’; and in paragraph (2) -- ‘(i) in the paragraph heading insert ‘LOAN AND LOAN GUARANTEE’ before ‘FUNDS’ and ‘(ii) in subparagraph (A), by inserting ‘for loans and loan guarantees’ before ‘under this subsection’; and SECTION 3. APPROPRIATIONS For this bill the Secretary of Agriculture shall appropriate $350 million for the program through the fiscal years 2019 through 2024 PLAIN ENGLISH SUMMARY: This legislation creates a grant program for broadband provides by amending the Rural Electrification Act of 1936
  12. Ms Vanderfleet (for herself and Mr. Sanders) submit A BILL To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. Short title. This Act may be cited as the “Medicare Drug Price Negotiation Act”. SEC. 2. Negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and establishment and application of formulary by the Secretary of Health and Human Services under Medicare part D. (a) In general.—Section 1860D–11 of the Social Security Act (42 U.S.C. 1395w–111) is amended by striking subsection (i) (relating to noninterference) and inserting the following: “(i) Negotiation of Lower Drug Prices; establishment and application of formulary.— “(1) NEGOTIATION.— “(A) IN GENERAL.—Notwithstanding any other provision of law, subject to subparagraph (B), the Secretary shall during a negotiation year and with respect to the negotiation drug grouping identified under subparagraph (C) with respect to such negotiation year— “(i) negotiate with pharmaceutical manufacturers the prices (including discounts, rebates, and all other price concessions) that may be charged for each plan year during the negotiated price period, with respect to such negotiation year, to PDP sponsors and MA organizations for covered part D drugs identified as included within such negotiation drug grouping for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan; and “(ii) complete such negotiations 30 days before the first day of the application review process for the first plan year during such negotiated price period for new contracts or expanding existing contracts with PDP sponsors and MA organizations to offer prescription drug plans or MA–PD plans, respectively. “(B) USE OF FALLBACK IF NEGOTIATIONS FAIL.—If, after attempting to negotiate the price during a negotiation year for a covered part D drug that is identified as included within the negotiation drug grouping for such negotiation year, the Secretary is not successful in obtaining an appropriate price (as determined by the Secretary in accordance with guidance described in subparagraph (E)), the price that may be charged during each plan year during the negotiated price period, with respect to such negotiation year, to PDP sponsors and MA organizations for such covered part D drugs for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan shall be the lowest of— “(i) the contract price applied pursuant to section 8126 of title 38, United States Code, for such drug for the contract year (as defined in such section 8126) beginning during the first plan year of such negotiated price period; “(ii) the average of the prices available, during the most recent 12-month period for which data is available prior to the beginning of such negotiated price period, from the manufacturer to any wholesaler, retailer, provider, health maintenance organization, nonprofit entity, or governmental entity in the ten OECD (Organization for Economic Cooperation and Development) countries that have the largest gross domestic product with a per capita income that is not less than half the per capita income of the United States, as reported by the manufacturer to the Secretary; and “(iii) the best price determined under section 1927(c)(1)(C) for such drug for the most recent rebate period (as defined in section 1927(k)(8)) applicable to such first plan year of such negotiated price period. “(C) IDENTIFICATION OF NEGOTIATION DRUG GROUPINGS.— “(i) IN GENERAL.—For each negotiation year, the Secretary shall, during the previous year, in accordance with the subsequent clauses of this subparagraph, and pursuant to rulemaking, identify covered part D drugs for which negotiations under subparagraph (A) shall be conducted during such negotiation year. In this subsection, all such covered part D drugs so identified for a negotiation year are collectively referred to as the negotiation drug grouping, with respect to such year. “(ii) IDENTIFICATION OF PRIORITIZED DRUGS.—In carrying out clause (i), except as provided under clause (iii), the Secretary may not identify for inclusion within the negotiation drug grouping with respect to a negotiation year, a covered part D drug that is not a drug prioritized pursuant to subparagraph (D) before all covered part D drugs that are so prioritized have been identified for inclusion in such grouping or in a negotiation drug grouping with respect to a previous negotiation year for which the negotiated price period has not expired. “(iii) DRUG INCLUSIONS FOR PRICE RENEGOTIATIONS.—In the case of a covered part D drug that is identified as included in a negotiation drug grouping under this subparagraph, with respect to a negotiation year, such covered part D drug shall be identified as included within the negotiation drug grouping for each subsequent third negotiation year. “(iv) REASONABLE NOTIFICATION.—The Secretary shall carry out this subparagraph in such manner as to provide for public notification of the negotiation drug grouping identified with respect to a negotiation year within a reasonable period before the beginning of such negotiation year. “(D) PRIORITIZATION.—For purposes of subparagraph (C)(ii), for a negotiation drug grouping, with respect to a negotiation year, the Secretary shall prioritize covered part D drugs— “(i) with respect to which the cost of such a drug to the part D eligible individual involved would exceed the annual out-of-pocket threshold applicable under section 1860D–2(b)(4)(B) for such negotiation year, if the drug were prescribed to the individual for the period of the year or with respect to which a single treatment regimen is priced above such annual out-of-pocket threshold applicable under such section 1860D–2(b)(4)(B) for the year; “(ii) that are among— “(I) the 40 covered part D drugs that are utilized by at least 1,000 Medicare part D beneficiaries and with respect to which there were the highest total expenditures under this part during the most recent 12-month period prior to the beginning of such negotiation year for which data is available; “(II) the 40 covered part D drugs that are utilized by at least 1,000 Medicare part D beneficiaries with respect to whom the total annual spending per such a beneficiary under this part for coverage of such a drug is at least $10,000; or “(III) the 20 covered part D drugs that are utilized by at least 1,000 Medicare part D beneficiaries and with respect to which there are unit cost increases at or above the 95th percentile of overall covered part D drug unit cost increases during the most recent 12-month period prior to the beginning of such negotiation year for which data is available; or “(iii) that are single-source drugs or biologicals (as defined in section 1847A(c)(6)(D)) and that satisfy at least one other criterion described in a previous clause of this subparagraph. “(E) GUIDANCE.—Not later than 6 months before the Secretary begins negotiations under subparagraph (A) for the first negotiation year, the Secretary shall issue guidance on criteria to be considered for purposes of determining under subparagraph (B) whether or not the Secretary is successful in obtaining an appropriate price for a covered part D drug. Such criteria shall include at least the following: “(i) The comparative clinical effectiveness and cost effectiveness, if available, of such covered part D drug. “(ii) The budgetary impact of providing coverage under this part for such covered part D drug. “(iii) The number of similarly effective drug or alternative treatment regimens for each approved use of such covered part D drug. “(iv) Associated unmet need or severity of illness. “(F) PUBLIC EXPLANATION ON NEGOTIATIONS OUTCOMES.—Not later than 30 days after the date on which the Secretary completes negotiations under this section during a negotiation year with a pharmaceutical manufacturer, with respect to the price for a covered part D drug for a negotiated price period, with respect to such year, the Secretary shall make publicly available an explanation of the outcome of such negotiations, based on the criteria included in the guidance issued pursuant to subparagraph (E). “(G) MEDPAC REPORT.— “(i) STUDY.—The Medicare Payment Advisory Commission shall conduct a study on the price negotiations conducted by the Secretary under this paragraph, including an analysis of— “(I) the extent to which such price negotiations are achieving lower prices for covered part D drugs for part D eligible individuals who are enrolled under a prescription drug plan or under an MA–PD plan; “(II) the parties benefitting from such lower prices, such as part D eligible individuals described in subclause (I), the Federal government, States, prescription drug plans and MA–PD plans, or other entities; “(III) how such price negotiations are affecting drug prices in the private market; and “(IV) how such price negotiations are affecting the list price of covered part D drugs. “(ii) REPORT.—Not later than January 1, 2022, the Medicare Payment Advisory Commission shall submit to Congress a report on the study conducted under clause (i), including recommendations for improving price negotiations described in clause (i). “(H) DEFINITIONS.—For purposes of this paragraph: “(i) NEGOTIATION YEAR.—The term ‘negotiation year’ means a year beginning with 2019. “(ii) NEGOTIATED PRICE PERIOD.—The term ‘negotiated price period’ means, with respect to a negotiation year and negotiation drug grouping, the 3-plan year period beginning with the first plan year beginning after the negotiation year for such grouping. “(2) ESTABLISHMENT AND APPLICATION OF FORMULARY BY THE SECRETARY OR CHANGES IN FORMULARIES TO BE REQUIRED BY SECRETARY.— “(A) IN GENERAL.—The Secretary shall, for plan years beginning with plan year 2019— “(i) subject to subparagraphs (B) and (C), establish and apply a formulary for required use by sponsors of prescription drug plans and organizations offering MA–PD plans under this part; or “(ii) require changes, as necessary, in the covered part D drugs included on formularies of PDP sponsors of prescription drug plans (including changes, as necessary, in the preferred or tiered cost-sharing status of such a drug) to take into account negotiations carried out by the Secretary pursuant to paragraph (1), regardless of whether such a covered part D drug is the subject of such negotiations. “(B) REQUIRED INCLUSION OF DRUGS IN ALL THERAPEUTIC CATEGORIES.—A formulary established and applied under subparagraph (A)(i) shall include at least two covered part D drugs in each category and class of covered part D drugs as described in section 423.120(b)(2)(i) of title 42, Code of Federal Regulations (as in effect on January 1, 2017). “(C) APPLICATION OF DEVELOPMENT AND REVISION REQUIREMENTS AND REQUIRED INCLUSION OF ALL DRUGS IN CERTAIN CATEGORIES AND CLASSES.—The requirements described in subparagraphs (A) and (B) of section 1860D–4(b)(3) (relating to development and revision requirements of the formulary) and subparagraph (G) of such section (relating to required inclusion of all drugs in certain categories and classes) shall apply to a formulary established and applied under subparagraph (A)(i) of this paragraph. “(3) PLAN FLEXIBILITY TO NEGOTIATE GREATER DISCOUNTS.—Nothing in this subsection shall be construed as preventing the sponsor of a prescription drug plan, or an organization offering an MA–PD plan, from obtaining a discount or reduction of the price for a covered part D drug below the price negotiated under paragraph (1), if applicable, including through the use of preferred or tiered cost-sharing status. “(4) ENSURING BENEFICIARY ACCESS TO NEEDED DRUGS.—Beginning with plan year 2019, Each PDP sponsor of a prescription drug plan and organization offering an MA–PD plan shall have in place a process under which an enrollee in the plan may request coverage under the plan for a covered part D drug that is not on the formulary, or is subject to utilization management controls, such as tiered pricing, prior authorization, or step therapy.”. (b) Conforming amendments.—Section 1860D–4 of the Social Security Act (42 U.S.C. 1395w–104) is amended— (1) in subsection (b)(3), in the matter preceding subparagraph (A), by striking “If a PDP” and inserting “Subject to section 1860D–11(i)(2), if a PDP”; (2) in subsection (g)— (A) in paragraph (1), by inserting before the period at the end the following: “, except that the PDP sponsor of a prescription drug plan shall treat the presentation of a prescription to a participating pharmacy, which is transmitted to the plan by the pharmacy, as a request for a coverage determination (including with respect to prior authorization, step therapy, or quantity limits) and, in applying such paragraphs of section 1852(g), the response to such transmittal shall be treated as a determination by the sponsor”; and (B) in paragraph (2), in the first sentence, by inserting “(or a participating pharmacy, on behalf of such individual, through transmission of a prescription as described in paragraph (1))” after “a part D eligible individual who is enrolled in the plan”; and (3) in subsection (h)— (A) in paragraph (1), in the second sentence, by inserting “(or a participating pharmacy, on behalf of such individual)” after “the part D eligible individual”; and (B) in paragraph (2), by inserting “(or a participating pharmacy, on behalf of such individual)” after “A part D eligible individual who is enrolled in a prescription drug plan offered by a PDP sponsor”. (4) EFFECTIVE DATE.—The amendments made by paragraphs (2) and (3) shall apply to plans years beginning on or after January 1, 2019. SEC. 3. Requiring drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals. (a) In general.—Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended— (1) in subsection (e)(1), in the matter preceding subparagraph (A), by inserting “and subsection (f)” after “this subsection”; and (2) by adding at the end the following new subsection: “(f) Prescription drug rebate agreement for rebate eligible individuals.— “(1) REQUIREMENT.— “(A) IN GENERAL.—For plan years beginning on or after January 1, 2019, in this part, the term ‘covered part D drug’ does not include any drug or biological product that is manufactured by a manufacturer that has not entered into and have in effect a rebate agreement described in paragraph (2). “(B) 2019 PLAN YEAR REQUIREMENT.—Any drug or biological product manufactured by a manufacturer that declines to enter into a rebate agreement described in paragraph (2) for the period beginning on January 1, 2019, and ending on December 31, 2019, shall not be included as a ‘covered part D drug’ for the subsequent plan year. “(2) REBATE AGREEMENT.—A rebate agreement under this subsection shall require the manufacturer to provide to the Secretary a rebate for each rebate period (as defined in paragraph (6)(B)) ending after December 31, 2018, in the amount specified in paragraph (3) for any covered part D drug of the manufacturer dispensed after December 31, 2018, to any rebate eligible individual (as defined in paragraph (6)(A)) for which payment was made by a PDP sponsor or MA organization under this part for such period, including payments passed through the low-income and reinsurance subsidies under sections 1860D–14 and 1860D–15(b), respectively. Such rebate shall be paid by the manufacturer to the Secretary not later than 30 days after the date of receipt of the information described in section 1860D–12(b)(7), including as such section is applied under section 1857(f)(3), or 30 days after the receipt of information under subparagraph (D) of paragraph (3), as determined by the Secretary. Insofar as not inconsistent with this subsection, the Secretary shall establish terms and conditions of such agreement relating to compliance, penalties, and program evaluations, investigations, and audits that are similar to the terms and conditions for rebate agreements under paragraphs (3) and (4) of section 1927(b). “(3) REBATE FOR REBATE ELIGIBLE MEDICARE DRUG PLAN ENROLLEES.— “(A) IN GENERAL.—The amount of the rebate specified under this paragraph for a manufacturer for a rebate period, with respect to each dosage form and strength of any covered part D drug provided by such manufacturer and dispensed to a rebate eligible individual, shall be equal to the product of— “(i) the total number of units of such dosage form and strength of the drug so provided and dispensed for which payment was made by a PDP sponsor or an MA organization under this part for the rebate period, including payments passed through the low-income and reinsurance subsidies under sections 1860D–14 and 1860D–15(b), respectively; and “(ii) the amount (if any) by which— “(I) the Medicaid rebate amount (as defined in subparagraph (B)) for such form, strength, and period, exceeds “(II) the average Medicare drug program rebate eligible rebate amount (as defined in subparagraph (C)) for such form, strength, and period. “(B) MEDICAID REBATE AMOUNT.—For purposes of this paragraph, the term ‘Medicaid rebate amount’ means, with respect to each dosage form and strength of a covered part D drug provided by the manufacturer for a rebate period— “(i) in the case of a single source drug or an innovator multiple source drug, the amount specified in paragraph (1)(A)(ii)(II) or (2)(C) of section 1927(c) plus the amount, if any, specified in subparagraph (A)(ii) of paragraph (2) of such section, for such form, strength, and period; or “(ii) in the case of any other covered outpatient drug, the amount specified in paragraph (3)(A)(i) of such section for such form, strength, and period. “(C) AVERAGE MEDICARE DRUG PROGRAM REBATE ELIGIBLE REBATE AMOUNT.—For purposes of this subsection, the term ‘average Medicare drug program rebate eligible rebate amount’ means, with respect to each dosage form and strength of a covered part D drug provided by a manufacturer for a rebate period, the sum, for all PDP sponsors under part D and MA organizations administering an MA–PD plan under part C, of— “(i) the product, for each such sponsor or organization, of— “(I) the sum of all rebates, discounts, or other price concessions (not taking into account any rebate provided under paragraph (2) or any discounts under the program under section 1860D–14A) for such dosage form and strength of the drug dispensed, calculated on a per-unit basis, but only to the extent that any such rebate, discount, or other price concession applies equally to drugs dispensed to rebate eligible Medicare drug plan enrollees and drugs dispensed to PDP and MA–PD enrollees who are not rebate eligible individuals; and “(II) the number of the units of such dosage and strength of the drug dispensed during the rebate period to rebate eligible individuals enrolled in the prescription drug plans administered by the PDP sponsor or the MA–PD plans administered by the MA organization; divided by “(ii) the total number of units of such dosage and strength of the drug dispensed during the rebate period to rebate eligible individuals enrolled in all prescription drug plans administered by PDP sponsors and all MA–PD plans administered by MA organizations. “(D) USE OF ESTIMATES.—The Secretary may establish a methodology for estimating the average Medicare drug program rebate eligible rebate amounts for each rebate period based on bid and utilization information under this part and may use these estimates as the basis for determining the rebates under this section. If the Secretary elects to estimate the average Medicare drug program rebate eligible rebate amounts, the Secretary shall establish a reconciliation process for adjusting manufacturer rebate payments not later than 3 months after the date that manufacturers receive the information collected under section 1860D–12(b)(7)(B). “(4) LENGTH OF AGREEMENT.—The provisions of paragraph (4) of section 1927(b) (other than clauses (iv) and (v) of subparagraph (B)) shall apply to rebate agreements under this subsection in the same manner as such paragraph applies to a rebate agreement under such section. “(5) OTHER TERMS AND CONDITIONS.—The Secretary shall establish other terms and conditions of the rebate agreement under this subsection, including terms and conditions related to compliance, that are consistent with this subsection. “(6) DEFINITIONS.—In this subsection and section 1860D–12(b)(7): “(A) REBATE ELIGIBLE INDIVIDUAL.—The term ‘rebate eligible individual’ means— “(i) a subsidy eligible individual (as defined in section 1860D–14(a)(3)(A)); “(ii) a Medicaid beneficiary treated as a subsidy eligible individual under clause (v) of section 1860D–14(a)(3)(B); and “(iii) any part D eligible individual not described in clause (i) or (ii) who is determined for purposes of the State plan under title XIX to be eligible for medical assistance under clause (i), (iii), or (iv) of section 1902(a)(10)(E). “(B) REBATE PERIOD.—The term ‘rebate period’ has the meaning given such term in section 1927(k)(8).”. (b) Reporting requirement for the determination and payment of rebates by manufacturers related to rebate for rebate eligible Medicare drug plan enrollees.— (1) REQUIREMENTS FOR PDP SPONSORS.—Section 1860D–12(b) of the Social Security Act (42 U.S.C. 1395w–112(b)) is amended by adding at the end the following new paragraph: “(7) REPORTING REQUIREMENT FOR THE DETERMINATION AND PAYMENT OF REBATES BY MANUFACTURERS RELATED TO REBATE FOR REBATE ELIGIBLE MEDICARE DRUG PLAN ENROLLEES.— “(A) IN GENERAL.—For purposes of the rebate under section 1860D–2(f) for contract years beginning on or after January 1, 2019, each contract entered into with a PDP sponsor under this part with respect to a prescription drug plan shall require that the sponsor comply with subparagraphs (B) and (C). “(B) REPORT FORM AND CONTENTS.—Not later than a date specified by the Secretary, a PDP sponsor of a prescription drug plan under this part shall report to each manufacturer— “(i) information (by National Drug Code number) on the total number of units of each dosage, form, and strength of each drug of such manufacturer dispensed to rebate eligible Medicare drug plan enrollees under any prescription drug plan operated by the PDP sponsor during the rebate period; “(ii) information on the price discounts, price concessions, and rebates for such drugs for such form, strength, and period; “(iii) information on the extent to which such price discounts, price concessions, and rebates apply equally to rebate eligible Medicare drug plan enrollees and PDP enrollees who are not rebate eligible Medicare drug plan enrollees; and “(iv) any additional information that the Secretary determines is necessary to enable the Secretary to calculate the average Medicare drug program rebate eligible rebate amount (as defined in paragraph (3)(C) of such section), and to determine the amount of the rebate required under this section, for such form, strength, and period. Such report shall be in a form consistent with a standard reporting format established by the Secretary. “(C) SUBMISSION TO SECRETARY.—Each PDP sponsor shall promptly transmit a copy of the information reported under subparagraph (B) to the Secretary for the purpose of audit oversight and evaluation. “(D) CONFIDENTIALITY OF INFORMATION.—The provisions of subparagraph (D) of section 1927(b)(3), relating to confidentiality of information, shall apply to information reported by PDP sponsors under this paragraph in the same manner that such provisions apply to information disclosed by manufacturers or wholesalers under such section, except— “(i) that any reference to ‘this section’ in clause (i) of such subparagraph shall be treated as being a reference to this section; “(ii) the reference to the Director of the Congressional Budget Office in clause (iii) of such subparagraph shall be treated as including a reference to the Medicare Payment Advisory Commission; and “(iii) clause (iv) of such subparagraph shall not apply. “(E) OVERSIGHT.—Information reported under this paragraph may be used by the Inspector General of the Department of Health and Human Services for the statutorily authorized purposes of audit, investigation, and evaluations. “(F) PENALTIES FOR FAILURE TO PROVIDE TIMELY INFORMATION AND PROVISION OF FALSE INFORMATION.—In the case of a PDP sponsor— “(i) that fails to provide information required under subparagraph (B) on a timely basis, the sponsor is subject to a civil money penalty in the amount of $10,000 for each day in which such information has not been provided; or “(ii) that knowingly (as defined in section 1128A(i)) provides false information under such subparagraph, the sponsor is subject to a civil money penalty in an amount not to exceed $100,000 for each item of false information. Such civil money penalties are in addition to other penalties as may be prescribed by law. The provisions of section 1128A (other than subsections (a) and (b)) shall apply to a civil money penalty under this subparagraph in the same manner as such provisions apply to a penalty or proceeding under section 1128A(a).”. (2) APPLICATION TO MA ORGANIZATIONS.—Section 1857(f)(3) of the Social Security Act (42 U.S.C. 1395w–27(f)(3)) is amended by adding at the end the following: “(D) REPORTING REQUIREMENT RELATED TO REBATE FOR REBATE ELIGIBLE MEDICARE DRUG PLAN ENROLLEES.—Section 1860D–12(b)(7).”. (c) Deposit of rebates into Medicare Prescription Drug Account.—Section 1860D–16(c) of the Social Security Act (42 U.S.C. 1395w–116(c)) is amended by adding at the end the following new paragraph: “(6) REBATE FOR REBATE ELIGIBLE MEDICARE DRUG PLAN ENROLLEES.—Amounts paid under a rebate agreement under section 1860D–2(f) shall be deposited into the Account.”. (d) Exclusion from determination of best price and average manufacturer price under Medicaid.— (1) EXCLUSION FROM BEST PRICE DETERMINATION.—Section 1927(c)(1)(C)(ii)(I) of the Social Security Act (42 U.S.C. 1396r–8(c)(1)(C)(ii)(I)) is amended by inserting “and amounts paid under a rebate agreement under section 1860D–2(f)” after “this section”. (2) EXCLUSION FROM AVERAGE MANUFACTURER PRICE DETERMINATION.—Section 1927(k)(1)(B)(i) of the Social Security Act (42 U.S.C. 1396r–8(k)(1)(B)(i)) is amended— (A) in subclause (IV), by striking “and” after the semicolon; (B) in subclause (V), by striking the period at the end and inserting “; and”; and (C) by adding at the end the following: “(VI) amounts paid under a rebate agreement under section 1860D–2(f).”.
  13. Doomhammer

    JAWS Act

    Ms. Vanderfleet (for herself and Mr. Blake) submit A BILL To prohibit importation of seafood products of countries that do not prohibit the practice of shark finning, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the “Justice Attributed to Wounded Sharks Act” or “JAWS Act”. SEC. 2. PROHIBITION ON IMPORTATION OF SEAFOOD PRODUCTS OF COUNTRIES THAT DO NOT PROHIBIT THE PRACTICE OF SHARK FINNING. (a) In General.—No seafood product that is the growth or product of a country described in subsection (b) may be imported into the customs territory of the United States on or after the date that is 90 days after the date of the enactment of this Act. (b) Country Described.—A country described in this subsection is a country with respect to which the President determines does not prohibit the following: (1) Shark finning in the territorial waters of the country. (2) The importation, sale, or possession of shark fins obtained as a result of shark finning. (c) Definitions.—In this section: (1) CUSTOMS TERRITORY OF THE UNITED STATES.—The term “customs territory of the United States” has the meaning given such term in general note 2 of the Harmonized Tariff Schedule of the United States. (2) SEAFOOD PRODUCT.—The term “seafood product” means any article that is classified under chapter 3 of the Harmonized TariffSchedule of the United States. (3) SHARK FINNING.—The term “shark finning” has the meaning given the term in section 9 of the Shark Finning Prohibition Act (16 U.S.C. 1822 note).
  14. Ms. Vanderfleet (for herself and Mr. Garrett) submits A BILL To limit the application of Federal laws to the distribution and consumption of marihuana, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. Short title. This Act may be cited as the “Ending Federal Marijuana Prohibition Act”. SEC. 2. Application of the Controlled Substances Act to marijuana. (a) In general.—Part A of the Controlled Substances Act (21 U.S.C. 801 et seq.) is amended by adding at the end the following: “SEC. 103. Application of this Act to marijuana. “(a) Prohibition on certain shipping or transportation.—This Act shall not apply to marijuana, except that it shall be unlawful only to ship or transport, in any manner or by any means whatsoever, marijuana, from one State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, into any other State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, or from any foreign country into any State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof, when such marijuana is intended, by any person interested therein, to be received, possessed, sold, or in any manner used, either in the original package or otherwise, in violation of any law of such State, territory, or district of the United States, or place noncontagious to but subject to the jurisdiction thereof. “(b) Penalty.—Whoever knowingly violates subsection (a) shall be fined under title 18, United States Code, imprisoned not more than 1 year, or both.”. (b) Table of contents.—The table of contents for the Comprehensive Drug Abuse Prevention and Control Act of 1970 (Public Law 91–513; 84 Stat. 1236) is amended by striking the item relating to section 103 and inserting the following: “Sec. 103. Application of this Act to marijuana.”. SEC. 3. Deregulation of marijuana. (a) Removed from schedule of controlled substances.—Subsection (c) of Schedule I of section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended— (1) by striking “marijuana”; and (2) by striking “tetrahydrocannabinols”. (b) Removal of prohibition on import and export.—Section 1010(b) of the Controlled Substances Import and Export Act (21 U.S.C. 960) is amended— (1) in paragraph (1)— (A) in subparagraph (F), by inserting “or” after the semicolon; (B) by striking subparagraph (G); and (C) by redesignating subparagraph (H) as subparagraph (G); (2) in paragraph (2)— (A) in subparagraph (F), by inserting “or” after the semicolon; (B) by striking subparagraph (G); and (C) by redesignating subparagraph (H) as subparagraph (G); (3) in paragraph (3), by striking “paragraphs (1), (2), and (4)” and inserting “paragraphs (1) and (2)”; (4) by striking paragraph (4); and (5) by redesignating paragraphs (5), (6), and (7) as paragraphs (4), (5), and (6), respectively. SEC. 4. Conforming amendments to Controlled Substances Act. The Controlled Substances Act (21 U.S.C. 801 et seq.) is amended— (1) in section 102(44) (21 U.S.C. 802(44)), by striking “marijuana,”; (2) in section 401(b) (21 U.S.C. 841(b))— (A) in paragraph (1)— (i) in subparagraph (A)— (I) in clause (vi), by inserting “or” after the semicolon; (II) by striking (vii); and (III) by redesignating clause (viii) as clause (vii); (ii) in subparagraph (B)— (I) by striking clause (vii); and (II) by redesignating clause (viii) as clause (vii); (iii) in subparagraph (C), by striking “subparagraphs (A), (B), and (D)” and inserting “subparagraphs (A) and (B)”; (iv) by striking subparagraph (D); (v) by redesignating subparagraph (E) as subparagraph (D); and (vi) in subparagraph (D)(i), as redesignated, by striking “subparagraphs (C) and (D)” and inserting “subparagraph (C)”; (B) by striking paragraph (4); and (C) by redesignating paragraphs (5), (6), and (7) as paragraphs (4), (5), and (6), respectively; (3) in section 402(c)(2)(B) (21 U.S.C. 842(c)(2)(B)), by striking “, marijuana,”; (4) in section 403(d)(1) (21 U.S.C. 843(d)(1)), by striking “, marijuana,”; (5) in section 418(a) (21 U.S.C. 859(a)), by striking the last sentence; (6) in section 419(a) (21 U.S.C. 860(a)), by striking the last sentence; (7) in section 422(d) (21 U.S.C. 863(d))— (A) in the matter preceding paragraph (1), by striking “marijuana,”; and (B) in paragraph (5), by striking “, such as a marijuana cigarette,”; and (8) in section 516(d) (21 U.S.C. 886(d)), by striking “section 401(b)(6)” each place the term appears and inserting “section 401(b)(5)”.
  15. Ms. Vanderfleet (for herself, Ms. Warren, and Mr. Miller) submit A BILL To repeal the authority under the National Labor Relations Act for States to enact laws prohibiting agreements requiring membership in a labor organization as a condition of employment, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. Short title. This Act may be cited as the “Protecting Workers and Improving Labor Standards Act”. SEC. 2. Preempting State right-to-work laws. Subsection (b) of section 14 of the National Labor Relations Act (29 U.S.C. 164) is repealed.
×